发明名称 COMPOSITION AND DOSAGE FORM FOR DELAYED GASTRIC RELEASE OF ALENDRONATE AND/OR OTHER BIS-PHOSPHONATES
摘要 The present invention provides compacted pharmaceutical composition for oral administration to a patient which expands upon contact with gastric fluid to retain a dosage form in the patient's stomach for an extended period of time, the formulation comprising a non-hydrated hydrogel, a superdisintegrant and tannic acid. The present invention further provides a pharmaceutical dosage form containing an active ingredient, and the compacted pharmaceutical composition. The invention further provides a dosage form suitable for delivering a therapeutic bis-phosphonate such as alendronate to the stomach of a patient over an extended period.
申请公布号 WO0200204(A1) 申请公布日期 2002.01.03
申请号 WO2001US20130 申请日期 2001.06.22
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;FLASHNER-BARAK, MOSHE;ROSENBERGER, VERED;DAHAN, MAZAL;LERNER, YITZHAK 发明人 FLASHNER-BARAK, MOSHE;ROSENBERGER, VERED;DAHAN, MAZAL;LERNER, YITZHAK
分类号 A61K9/20;A61K9/22;A61K9/28;A61K9/34;A61K9/36;A61K31/663;A61K47/04;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61P3/14;A61P19/00;A61P19/08;A61P19/10;(IPC1-7):A61K9/22 主分类号 A61K9/20
代理机构 代理人
主权项
地址